Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 13, 2022
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
Erin Wright Maintained (XRAY) at Buy with Decreased Target to $42 on, Oct 13th, 2022
Erin Wright of Morgan Stanley, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Buy with Decreased Target from $44 to $42 on, Oct 13th, 2022.
Erin has made no other calls on XRAY in the last 4 months.
There are 2 other peers that have a rating on XRAY. Out of the 2 peers that are also analyzing XRAY, 1 agrees with Erin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $41 on, Thursday, July 21st, 2022
This is the rating of the analyst that currently disagrees with Erin
- John Kreger of "William Blair" Downgraded from Hold to Sell on, Friday, August 5th, 2022
